본문 바로가기
KERD
논문KCI 등재

Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

In terms of years of life lost to premature mortality, cancer imposes the highest burden in Korea. In order to reduce the burden of cancer, the Korean government has implemented cancer control programs aiming to reduce cancer incidence, to increase survival rates, and to decrease cancer mortality. However, these programs may paradoxically increase the cost burden. For examples, a cancer screening program for early detection could bring about over-diagnosis and over-treatment, and supplying medical services in a paternalistic manner could lead to defensive medicine or futile care. As a practical measure to reduce the cost burden of cancer, appropriate cancer care should be established. Ensuring appropriateness requires patient-doctor communication to ensure that utility values are shared and that autonomous decisions are made regarding medical services. Thus, strategies for reducing the cost burden of cancer through ensuring appropriate patient-centered care include introducing value-based medicine, conducting cost-utility studies, and developing patient decision aids.

Abstract

In terms of years of life lost to premature mortality, cancer imposes the highest burden in Korea. In order to reduce the burden of cancer, the Korean government has implemented cancer control programs aiming to reduce cancer incidence, to increase survival rates, and to decrease cancer mortality. However, these programs may paradoxically increase the cost burden. For examples, a cancer screening program for early detection could bring about over-diagnosis and over-treatment, and supplying medical services in a paternalistic manner could lead to defensive medicine or futile care. As a practical measure to reduce the cost burden of cancer, appropriate cancer care should be established. Ensuring appropriateness requires patient-doctor communication to ensure that utility values are shared and that autonomous decisions are made regarding medical services. Thus, strategies for reducing the cost burden of cancer through ensuring appropriate patient-centered care include introducing value-based medicine, conducting cost-utility studies, and developing patient decision aids.

참고문헌 (47)

  1. Williams A, "Calculating the global burden of disease: time for a strategic reappraisal?", Health Econ, 8(1), pp.1~8 (1999)
  2. Meropol NJ, "Cost of cancer care: issues and implications", J Clin Oncol, 25(2), pp.180~186 (2007)
  3. 윤석준, "Estimation of the Burden of Major Cancers in Korea", Journal of Korean Medical Science, 17(5), pp.604~610 (2002), 대한의학회
  4. Yoon SJ, "Current scope and perspective of burden of disease study based on health related quality of life", J Korean Med Assoc, 47(7), pp.600~602 (2004)
  5. Gong YH, "The burden of cancer in Korea during 2012: findings from a prevalence-based approach", J Korean Med Sci, 31(Suppl 2), pp.S168~S177 (2016)
  6. 윤석준, "Measuring the Burden of Disease in Korea", Journal of Korean Medical Science, 22(3), pp.518~523 (2007), 대한의학회
  7. Yoon J, "Disability-adjusted life years for 313 diseases and injuries: the 2012 Korean Burden of Disease Study", J Korean Med Sci, 31(Suppl 2), pp.S146~S157 (2016)
  8. Soerjomataram I, "Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer", BMC Med Res Methodol, 12, pp.125~ (2012)
  9. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014", Cancer Research and Treatment, 49(2), pp.292~305 (2017), 대한암학회
  10. Jung KW, "Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis", Asian Pac J Cancer Prev, 11(6), pp.1451~1457 (2010)
  11. 김영애, "The Economic Burden of Breast Cancer in Korea from 2007-2010", Cancer Research and Treatment, 47(4), pp.583~590 (2015), 대한암학회[DOI]
  12. Schnipper LE, "Value and cancer care: toward an equitable future", Clin Cancer Res, 16(24), pp.6004~6008 (2010)
  13. Ljung R, "Socioeconomic differences in the burden of disease in Sweden", Bull World Health Organ, 83(2), pp.92~99 (2005)
  14. Savage P, "Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014", Br J Cancer, 112(6), pp.1037~1041 (2015)
  15. Farmer P, "Expansion of cancer care and control in countries of low and middle income: a call to action", Lancet, 376(9747), pp.1186~1193 (2010)
  16. Steenland K, "An overview of methods for calculating the burden of disease due to specific risk factors", Epidemiology, 17(5), pp.512~519 (2006)
  17. Kim EJ, "Measuring the burden of chronic diseases in Korea in 2007", Public Health, 127(9), pp.806~813 (2013)
  18. 서민아, "Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013", Cancer Research and Treatment, 48(1), pp.1~10 (2016), 대한암학회[DOI]
  19. Løberg M, "Benefits and harms of mammography screening", Breast Cancer Res, 17, pp.63~ (2015)
  20. Gøtzsche PC, "Screening for breast cancer with mammography", Cochrane Database Syst Rev, (6), pp.CD001877~ (2013)
  21. Bae JM, "Overdiagnosis: epidemiologic concepts and estimation", Epidemiol Health, 37, pp.e2015004~ (2015)
  22. Bae JM, "Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean", Epidemiol Health, 37, pp.e2015015~ (2015)
  23. Welch HG, "Overdiagnosis in cancer", J Natl Cancer Inst, 102(9), pp.605~613 (2010)
  24. Bae JM, "It needs adaptation to the 2015 Korean guideline for breast cancer screening", J Korean Med Assoc, 58(9), pp.833~837 (2015)
  25. Jameson JL, "Precision medicine: personalized, problematic, and promising", N Engl J Med, 372(23), pp.2229~2234 (2015)
  26. Carlson RW, "Breast cancer. Clinical practice guidelines in oncology", J Natl Compr Canc Netw, 7(2), pp.122~192 (2009)
  27. Studdert DM, "Defensive medicine among high-risk specialist physicians in a volatile malpractice environment", JAMA, 293(21), pp.2609~2617 (2005)
  28. Earle CC, "Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?", J Clin Oncol, 26(23), pp.3860~3866 (2008)
  29. Brook RH, "Assessing the appropriateness of care--its time has come", JAMA, 302(9), pp.997~998 (2009)
  30. Dalton WS, "The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally", Clin Cancer Res, 16(24), pp.5987~5996 (2010)
  31. Bae JM, "Value-based medicine: concepts and application", Epidemiol Health, 37, pp.e2015014~ (2015)
  32. Bae JM, "Development and application of patient decision aids", Epidemiol Health, 37, pp.e2015018~ (2015)
  33. 배종면, "근거-진료 간극에 따른 의학연구의 방향", Hanyang Medical Reviews, 35(1), pp.3~8 (2015), 한양대학교 의과대학[DOI]
  34. Fujimori M, "Preferences of cancer patients regarding communication of bad news: a systematic literature review", Jpn J Clin Oncol, 39(4), pp.201~216 (2009)
  35. Grunfeld E, "Do available questionnaires measure the communication factors that patients and families consider important at end of life?", J Clin Oncol, 26(23), pp.3874~3878 (2008)
  36. Pollak KI, "Oncologist communication about emotion during visits with patients with advanced cancer", J Clin Oncol, 25(36), pp.5748~5752 (2007)
  37. McFarlane J, "SPIKE$: a six-step protocol for delivering bad news about the cost of medical care", J Clin Oncol, 26(25), pp.4200~4204 (2008)
  38. Meropol NJ, "American Society of Clinical Oncology guidance statement: the cost of cancer care", J Clin Oncol, 27(23), pp.3868~3874 (2009)
  39. Brown MM, "Health care economic analyses and value-based medicine", Surv Ophthalmol, 48(2), pp.204~223 (2003)
  40. Brown MM, "The burden of age-related macular degeneration: a value-based analysis", Curr Opin Ophthalmol, 17(3), pp.257~266 (2006)
  41. Neumann PJ, "Cancer therapy costs influence treatment: a national survey of oncologists", Health Aff (Millwood), 29(1), pp.196~202 (2010)
  42. Lenz M, "Decision aids for patients", Dtsch Arztebl Int, 109(22-23), pp.401~408 (2012)
  43. Trevena LJ, "Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers", BMC Med Inform Decis Mak, 13(Suppl 2), pp.S7~ (2013)
  44. Stacey D, "Decision aids for people facing health treatment or screening decisions", Cochrane Database Syst Rev, 4, pp.CD001431~ (2017)
  45. O’Connor AM, "Modifying unwarranted variations in health care: shared decision making using patient decision aids", Health Aff (Millwood), (Suppl Variation), pp.VAR63~VAR72 (2004)
  46. Döring AC, "Trigger finger: assessment of surgeon and patient preferences and priorities for decision making", J Hand Surg Am, 39(11), pp.2208~2213.e2 (2014)
  47. O’Connor AM, "Toward the ‘tipping point’: decision aids and informed patient choice", Health Aff (Millwood), 26(3), pp.716~725 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (7건)